Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920

Những quyển sách tương tự

• Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
  Bằng: Nauck, Michael A., et al.
  Được phát hành: (2019)
• Liraglutide and Glycaemic Outcomes in the LEADER Trial
  Bằng: Zinman, Bernard, et al.
  Được phát hành: (2018)
• Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
  Bằng: Verma, Subodh, et al.
  Được phát hành: (2019)
• Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial
  Bằng: Nauck, Michael A., et al.
  Được phát hành: (2018)
• Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
  Bằng: Crowley, Matthew J., et al.
  Được phát hành: (2020)